(Q42992694)

12 November 2017

title

Correlation of interferon treatment response with GBV-C/HGV genomic RNA and anti-envelope 2 protein antibody (English)

1 reference

12 November 2017

Tanaka T

1

1 reference

12 November 2017

Hess G

2

1 reference

12 November 2017

Schlueter V

3

1 reference

12 November 2017

Zdunek D

4

1 reference

12 November 2017

Tanaka S

5

1 reference

12 November 2017

Kohara M

6

1 reference

12 November 2017

publication date

1 April 1999

1 reference

Journal of Medical Virology

12 November 2017

published in

1 reference

12 November 2017

volume

57

1 reference

12 November 2017

issue

4

1 reference

12 November 2017

page(s)

370-375

1 reference

The cloning and clinical implications of HGV and HGBV-C.

12 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199904%2957%3A4%3C370%3A%3AAID-JMV8%3E3.0.CO%3B2-K

Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199904%2957%3A4%3C370%3A%3AAID-JMV8%3E3.0.CO%3B2-K

Recombinant interferon alfa therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199904%2957%3A4%3C370%3A%3AAID-JMV8%3E3.0.CO%3B2-K

Clinical implications of GBV-C/HGV infection in patients with "HCV-related" chronic hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199904%2957%3A4%3C370%3A%3AAID-JMV8%3E3.0.CO%3B2-K

Association between fulminant hepatic failure and a strain of GBV virus C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199904%2957%3A4%3C370%3A%3AAID-JMV8%3E3.0.CO%3B2-K

Significance of serum hepatitis C virus RNA levels in chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199904%2957%3A4%3C370%3A%3AAID-JMV8%3E3.0.CO%3B2-K

Effect of interferon-alpha and ribavirin therapy on serum GB virus C/hepatitis G virus (GBV-C/HGV) RNA levels in patients chronically infected with hepatitis C virus and GBV-C/HGV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199904%2957%3A4%3C370%3A%3AAID-JMV8%3E3.0.CO%3B2-K

Expression of the GB virus C E2 glycoprotein using the Semliki Forest virus vector system and its utility as a serologic marker

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199904%2957%3A4%3C370%3A%3AAID-JMV8%3E3.0.CO%3B2-K

Hepatitis G virus infection in chronic hepatitis C: frequency, features and response to interferon therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199904%2957%3A4%3C370%3A%3AAID-JMV8%3E3.0.CO%3B2-K

Isolation of novel virus-like sequences associated with human hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199904%2957%3A4%3C370%3A%3AAID-JMV8%3E3.0.CO%3B2-K

Detection of antibodies to a putative hepatitis G virus envelope protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199904%2957%3A4%3C370%3A%3AAID-JMV8%3E3.0.CO%3B2-K

Humoral immune response to the E2 protein of hepatitis G virus is associated with long-term recovery from infection and reveals a high frequency of hepatitis G virus exposure among healthy blood donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199904%2957%3A4%3C370%3A%3AAID-JMV8%3E3.0.CO%3B2-K

Epidemiology of genotypes of hepatitis C virus in Japanese patients with type C chronic liver diseases: a multi-institution analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199904%2957%3A4%3C370%3A%3AAID-JMV8%3E3.0.CO%3B2-K

Detection of the GBV-C hepatitis virus genome in serum from patients with fulminant hepatitis of unknown aetiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199904%2957%3A4%3C370%3A%3AAID-JMV8%3E3.0.CO%3B2-K

Detection of hepatitis C virus by polymerase chain reaction and response to interferon-alpha therapy: relationship to genotypes of hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199904%2957%3A4%3C370%3A%3AAID-JMV8%3E3.0.CO%3B2-K

Alphabet of hepatitis viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199904%2957%3A4%3C370%3A%3AAID-JMV8%3E3.0.CO%3B2-K

Molecular cloning and disease association of hepatitis G virus: a transfusion-transmissible agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199904%2957%3A4%3C370%3A%3AAID-JMV8%3E3.0.CO%3B2-K

HCV genotypes in chronic hepatitis C and response to interferon

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199904%2957%3A4%3C370%3A%3AAID-JMV8%3E3.0.CO%3B2-K

Hepatitis C virus genotypes 1 and 2 respond to interferon-alpha with different virologic kinetics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199904%2957%3A4%3C370%3A%3AAID-JMV8%3E3.0.CO%3B2-K

10.1002/(SICI)1096-9071(199904)57:4<370::AID-JMV8>3.0.CO;2-K

21 January 2018

Identifiers

DOI

1 reference

12 November 2017

1 reference